EUVIMEDEUVIMED entdecken
Crossref

Biological Activity of a 4-Hydroxy-Furanyl-Benzamide Derivative on Heart Failure

Figueroa-Valverde Lauro, Rosas-Nexticapa Marcela, López-Ramos Maria, Alvarez-Ramirez Magdalena, Mateu-Armad Maria Virginia, Díaz-Cedillo Francisco, Cervantes-Ortega Catalina, Melgarejo-Guutierrez Montserrat

Drug Research · 01.03.2023 · 73 (03) · 175-183

DOI: 10.1055/a-1855-1412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.03.2023. Verfasst von Figueroa-Valverde Lauro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaco-Chemistry, Faculty of Chemical Biological Sciences, University Autonomous of Campeche, Campeche, México. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Heart Failure. Die Arbeit nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are studies that suggest that some benzamide derivatives may exert effects on heart failure; however, their molecular mechanism is not very clear.

Objective

The aim of this research was to evaluate the biological activity of a 4-hydroxy-furanyl-benzamide derivative against heart failure translated as area infarct.

Methods

Biological activity produced by 4-hydroxy-furanyl-benzamide derivative against heart failure was determinate using an ischemia-reperfusion injury model. In addition, the effects exerted by the 4-hydroxy-furanyl-benzamide derivative on left ventricular pressure (LVP) was evaluated in the absence or presence of some drugs such as yohimbine, butaxamine, methoctramine and L-NAME using a model of rat heart isolated.

Results

The results showed that 4-hydroxy-furanyl-benzamide derivative decrease both infarct area and LVP. However, the effect produced by 4-hydroxy-furanyl-benzamide derivative on LVP was inhibited in the presence of both methoctramine and L-NAME.

Conclusions

All these data suggest that biological activity produced by 4-hydroxy-furanyl-benzamide derivative on left ventricular pressure is through of both M2-muscarinic receptor and nitric oxide synthase enzyme activation. It is important to mention that this phenomenon results as a decrease of both infarct area and heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryHeart FailureRatsAnimalsNG-Nitroarginine Methyl EsterInfarctionBenzamidesHeartDiamines

Substanzen

NG-Nitroarginine Methyl EsterBenzamidesmethoctramineDiamines

Autor:innen und Institutionen

  • Laboratory of Pharmaco-Chemistry, Faculty of Chemical Biological Sciences, University Autonomous of Campeche, Campeche, México.
  • Facultad de Nutrición, Universidad Veracruzana, Médicos y Odontologos s/n, Unidad del Bosque, Veracruz, México.
  • Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional. Prol, Santo Tomas, México.
  • Facultad de Medicina Universidad Veracruzana, Médicos y Odontologos s/n, Unidad del Bosque, Veracruz, México.

Zitieren

APA

Lauro, F. V., Marcela, R. N., Maria, L. R., Magdalena, A. R., Virginia, M. M., Francisco, D. C., Catalina, C. O., & Montserrat, M. G. (2023). Biological Activity of a 4-Hydroxy-Furanyl-Benzamide Derivative on Heart Failure. Drug Research, 73(03), 175-183. https://doi.org/10.1055/a-1855-1412

Vancouver

Lauro FV, Marcela RN, Maria LR, Magdalena AR, Virginia MM, Francisco DC, et al. Biological Activity of a 4-Hydroxy-Furanyl-Benzamide Derivative on Heart Failure. Drug Research. 2023;73(03):175-183. doi:10.1055/a-1855-1412

BibTeX
@article{Lauro2023,
  author = {Lauro, Figueroa-Valverde and Marcela, Rosas-Nexticapa and Maria, López-Ramos and Magdalena, Alvarez-Ramirez and Virginia, Mateu-Armad Maria and Francisco, Díaz-Cedillo and Catalina, Cervantes-Ortega and Montserrat, Melgarejo-Guutierrez},
  title = {Biological Activity of a 4-Hydroxy-Furanyl-Benzamide Derivative on Heart Failure},
  journal = {Drug Research},
  year = {2023},
  volume = {73},
  number = {03},
  pages = {175--183},
  doi = {10.1055/a-1855-1412}
}
Kostenlos starten →